Financials • Specialty Insurers
$54.61 ▲ +0.02
(+0.04%)
MKT CAP: $14.91B • VOL: 2.36M
52W L $35 52W H $56
EQH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.66B | $12.43B | $10.46B |
| YoY Revenue Growth % | -6.1% | +18.8% | — |
| Gross Profit | $5.13B | $5.47B | $4.60B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.6K | $1.5K | $1.5K |
| Operating Margin % | 0.0% | 0.0% | 0.0% |
| Net Income (GAAP) | -$1.4K | $1.3K | $1.3K |
| EBITDA (Normalized) | $419.9M | $447.3M | $376.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $714.0M | $2.01B | -$208.0M |
| Capital Expenditures (CapEx) | $524.9M | $559.1M | $470.7M |
| Free Cash Flow (FCF) | $189.1M | $1.45B | -$678.7M |
| FCF Margin % | 1.6% | 11.6% | -6.5% |
| Return on Invested Capital (ROIC %) | -45.0% | 95.0% | 0.0% |
| Cash & Short-Term Equivalents | $12.46B | $6.96B | $1.38B |
| Total Debt (Short + Long Term) | $3.83B | $3.83B | $2.94B |
| Total Stockholders' Equity | -$74.0M | $1.56B | $6.02B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR EQH.